VIM and neoplasm: Accordingly, Nijkamp and colleagues [44] demonstrated a potential correlation between the loss of E-cadherin and the presence of vimentin, indicating increased migratory capabilities in tumor cells and an increased risk of metastasis in patients with HNSCC.